Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1988 1
1996 2
1997 1
2001 2
2004 2
2006 1
2007 2
2008 4
2009 2
2010 1
2011 6
2012 4
2013 6
2014 3
2015 1
2016 2
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant trastuzumab in HER2-positive breast cancer.
Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J; Breast Cancer International Research Group. Slamon D, et al. N Engl J Med. 2011 Oct 6;365(14):1273-83. doi: 10.1056/NEJMoa0910383. N Engl J Med. 2011. PMID: 21991949 Free PMC article. Clinical Trial.
Cabazitaxel: a novel microtubule inhibitor.
Villanueva C, Bazan F, Kim S, Demarchi M, Chaigneau L, Thiery-Vuillemin A, Nguyen T, Cals L, Dobi E, Pivot X. Villanueva C, et al. Among authors: cals l. Drugs. 2011 Jul 9;71(10):1251-8. doi: 10.2165/11591390-000000000-00000. Drugs. 2011. PMID: 21770474 Review.
Chemoradiation in anaplastic thyroid carcinomas.
Sun XS, Sun SR, Guevara N, Fakhry N, Marcy PY, Lassalle S, Peyrottes I, Bensadoun RJ, Lacout A, Santini J, Cals L, Bosset JF, Garden AS, Thariat J. Sun XS, et al. Among authors: cals l. Crit Rev Oncol Hematol. 2013 Jun;86(3):290-301. doi: 10.1016/j.critrevonc.2012.10.006. Epub 2012 Dec 4. Crit Rev Oncol Hematol. 2013. PMID: 23218594 Review.
[Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy].
Bardet E, Bourhis J, Cals L, Fayette J, Guigay J, Hans S, Saint-Guily JL, Lagarde F, Lallemant B, Milano G, Rolland F, Lefebvre JL. Bardet E, et al. Among authors: cals l. Bull Cancer. 2009 Oct;96(10):1013-28. doi: 10.1684/bdc.2009.0951. Bull Cancer. 2009. PMID: 19744919 Free article. French.
[Prevalence and management of pain in patients with metastatic cancer in Franche-Comté].
Dénommé F, Kroemer M, Montcuquet P, Nallet G, Thiery-Vuillemin A, Bazan F, Mouillet G, Villanueva C, Demarchi M, Stein U, Almotlak H, Chaigneau L, Curtit E, Meneveau N, Maurina T, Dobi E, Hon TN, Cals L, Mansi L, Verlut C, Pana-Katatali H, Caubet M, Paillard MJ, Limat S, Pivot X, Nerich V. Dénommé F, et al. Among authors: cals l. Bull Cancer. 2016 Oct;103(10):849-860. doi: 10.1016/j.bulcan.2016.08.007. Epub 2016 Sep 29. Bull Cancer. 2016. PMID: 27692731 French.
[Follow-up in patients with early breast cancer].
Maurina T, Chaigneau L, Bazan F, Villanueva C, Thiery-Vuillemin A, Kalbacher E, Curtit E, Cals L, N'guyen T, Pivot X. Maurina T, et al. Among authors: cals l. Bull Cancer. 2011 Oct;98(9):1091-106. doi: 10.1684/bdc.2011.1431. Bull Cancer. 2011. PMID: 21908264 Free article. French.
[Pseudotumoral pelvic actinomycosis].
Collard O, Perraud P, Melani C, Nouyrigat P, Cals L. Collard O, et al. Among authors: cals l. Presse Med. 1996 May 4-11;25(16):776. Presse Med. 1996. PMID: 8692757 French. No abstract available.
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.
Pivot X, Romieu G, Debled M, Pierga JY, Kerbrat P, Bachelot T, Lortholary A, Espié M, Fumoleau P, Serin D, Jacquin JP, Jouannaud C, Rios M, Abadie-Lacourtoisie S, Venat-Bouvet L, Cany L, Catala S, Khayat D, Gambotti L, Pauporté I, Faure-Mercier C, Paget-Bailly S, Henriques J, Grouin JM; PHARE trial investigators. Pivot X, et al. Lancet. 2019 Jun 29;393(10191):2591-2598. doi: 10.1016/S0140-6736(19)30653-1. Epub 2019 Jun 6. Lancet. 2019. PMID: 31178155 Clinical Trial.
36 results